Human Immunodeficiency Virus (HIV). The outer shell, called the capsid (yellow and purple) envelopes the viral RNA genome (blue). Illustration credit: Janet Iwasa Accomplishing a feat that had been a ...

Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

Researchers at UVA School of Medicine have found long-sought answers to questions about HIV transmission, and the findings could lead to new ways to prevent the disease’s spread. More than 1 million ...

"HIV treatment is lifesaving but also lifelong," said Patrick Jackson, MD, one of the two lead authors on the paper. "Understanding how the virus stays latent in cells could help us develop a lasting ...

Beginning with an HIV diagnosis in 1990, Ivy Arce’s story spun into over three decades of activism, now unyielding in her demand for a cure. “For me, a cure is not a project,” she said. “Without ...

Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...

The HIV/AIDS epidemic spiked in the 1980s, resulting in the death of over 100,000 people from 1981 to 1990, making an irreversible mark on our world from a social, medical, and political perspective.

A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...

An early trial for an experimental HIV vaccine candidate has shown promising results. 97% of recipients in a phase 1 study showed immune system activity in response to the vaccine. But there's a long ...